Emivirine [clinicaltrials_resource:30668ce9eb0e39f781c4211c8d6f8f1a]
A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive [clinicaltrials:NCT00002215]A Study of MKC-442 in Combination With Other Anti-HIV Drugs [clinicaltrials:NCT00002412]A Study of MKC-442 in HIV-Positive Patients [clinicaltrials:NCT00002413]The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002418]The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002420]
intervention [clinicaltrials_vocabulary:intervention]
Emivirine [clinicaltrials_resource:30668ce9eb0e39f781c4211c8d6f8f1a]
Bio2RDF identifier
30668ce9eb0e39f781c4211c8d6f8f1a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:30668ce9eb0e39f781c4211c8d6f8f1a
intervention name [clinicaltrials_vocabulary:intervention-name]
identifier
clinicaltrials_resource:30668ce9eb0e39f781c4211c8d6f8f1a
title
Emivirine
@en
type
label
Emivirine [clinicaltrials_resource:30668ce9eb0e39f781c4211c8d6f8f1a]
@en